| Schmidt, Pascal (Marinomed 201808– CFO before Raymond James Financial + Mummert & Co + Infineon Ventures) |
Chief Financial Officer (CFO) |
|
|
| Schmidt, Thomas (Agilent 201306– OpenLAB CDS Product Manager before Waters before Creon LabControl) |
Product Manager (personnel) |
Agilent (Group) |
Germany |
| Schmidt, Walter (Affiris 201502– Supervisory Board Member before 200604 CEO + Co-founder before Co-founder Intercell) |
Supervisory Board Member |
Affiris GmbH |
Austria |
| Schmidt-Brand, Jan (Wilex 201404– CEO before CFO + Heidelberg Pharma 200109– CEO + CFO) |
Chief Executive Officer (CEO) |
Heidelberg Pharma (Group) |
Germany |
| Schmidt-Bäse, Dieter (Bio-Rad 201705 Sales Manager Central Europe) |
Sales Manager / Marketing Manager |
Bio-Rad (Group) |
Germany |
| Schmitt, Ansgar (BRAHMS 200906 VP BusDev) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Germany |
| Schmitt, Daniel M. (Actuate Therapeutics 202302 CEO) |
Chief Executive Officer (CEO) |
Actuate Therapeutics Inc. |
United States (USA) |
| Schmitt-dos Santos, Juliette (Andrew Lloyd & Associates 2012– Director joined 2002) |
Public Relations Manager / Investor Relations Manager |
Andrew Lloyd & Associates (ALA) |
France |
| Schmitz, Alexander (Endeavour Vision 201605) |
Investment Manager |
Endeavour Vision (Group) |
Switzerland |
| Schmitz, Andreas (NanoTemper 202207– Chief Human Resources Officer before Roche Germany + SAP) |
Managing Director |
NanoTemper (Group) |
Germany |
| Schmitz, O. (Univ Essen-Duisburg 201209– Prof Applied Analytical Chemistry before Univ Wuppertal) |
Professor |
University of Duisburg-Essen |
Germany |
| Schmukler, Lou (BMS 201410 President Global Manufacturing + Supply) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Schnee, Elmar (Cardiorentis 201110– CEO before Merck Serono S.A. 200701 CEO before Merck KGaA) |
Chief Executive Officer (CEO) |
Cardiorentis (Group) |
Switzerland |
| Schnegg, Elgar (Biocrates Life Sciences 200806–201306 CEO LEFT 6/13 before Sandoz/Hexal Austria + FMCG) |
Chief Executive Officer (CEO) |
Biocrates (Group) |
Austria |
| Schneider, Christian (Vesalius Biocapital 201006 Investment Manager before Polytechnos since 2001 before Centocor) |
Investment Manager |
Vesalius Biocapital (Group) |
Luxembourg |
| Schneider, Daniel (Dan) (Photocure 201811– CEO before Ablynx Inc + BTG International Inc + Somaxon + Sepracor) |
Chief Executive Officer (CEO) |
Photocure (Group) |
Norway |
| Schneider, Gabriele (ProBioGen 200309– Business Development) |
Business Development Manager / Strategy Manager |
Minapharm (Group) |
Germany |
| Schneider, Joerg (Oxxon Therapeutics 200610 VP Research + co-founder) |
Research & Development Manager |
Oxxon (Group) |
United States (USA) |
| Schneider, Mike (Applied Biosystems 200701 President Global Service Div) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Schneider, René (NeuroSearch 201110 CFO) |
Chief Financial Officer (CFO) |
NeuroSearch (Group) |
Denmark |
| Schneider, Susan (ThromboGenics 201711– CMO before Allergan) |
Chief Medical Officer (CMO) |
Oxurion (Group) |
Belgium |
| Schneider, Ulf Mark (Fresenius 201207 CEO) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
Germany |
| Schneiderbauer, Alois (Biotecon 2008– Managing Director + CBO before IBA GmbH 200401– CBO before CyBio before MWG) |
Managing Director |
EW Group (Erich Wesjohann) (Group) |
Germany |
| Schneiderman, Daniel (Biophytis 201907 CFO) |
Chief Financial Officer (CFO) |
Biophytis (Group) |
France |
| Schnell, Beate (InSphero 201601– Head of Sales before Promega + Abbott Diagnostics) |
Sales Manager / Marketing Manager |
InSphero (Group) |
Switzerland |
| Schnell, Ralf (Siemens 201408 General Partner at Siemens Financial Services Venture Capital) |
General Partner (venture partner) |
Siemens (Group) |
Germany |
| Schnieders, Frank (Lampseq Diagnostics 202108– Managing Director before Provecs Medical) |
Managing Director |
Lampseq Diagnostics GmbH |
Germany |
| Schnittker, Christopher P. (Micromet 200610 Vice President + CFO) |
Chief Financial Officer (CFO) |
Amgen (Group) |
United States (USA) |
| Schnitzler, Jan (Sidney Kimmel Cancer Center 200808) |
n. a. |
Johns Hopkins University |
United States (USA) |
| Schoenbeck, Uwe (Pfizer 202110 SVP + CSO for Emerging Science + Innovation) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pfizer (Group) |
United States (USA) |
| Schoening, Stephanie (Monarch LifeSciences 200911 Marketing Director) |
Sales Manager / Marketing Manager |
Monarch LifeSciences LLC |
United States (USA) |
| Schoeny, Don (Protedyne 200210 CEO before CytoLogix CEO before Qiagen VP Commcerical Operations + PerSeptive + HP) |
Chief Executive Officer (CEO) |
LabCorp (Group) |
United States (USA) |
| Schofield, Jake (Labstep Ltd 201806 CEO + Founder) |
Chief Executive Officer (CEO) |
Labstep Ltd. |
United Kingdom (GB) |
| Scholefield, Graham (Scitaris 202204 Managing Partner) |
Managing Partner |
Scitaris (Group) |
Germany |
| Scholl, Michael (Leukocare AG 201105 CEO) |
Chief Executive Officer (CEO) |
Leukocare (Group) |
Germany |
| Schollmeier, Klaus (SuppreMol 201304– Managing Director before Santhera CEO + ING BHF-Bank + Abbott/Knoll/BASF) |
Managing Director |
Baxter (Group) |
Germany |
| Schork, Stefan (Artel 201106 Business Development Europe) |
Business Development Manager / Strategy Manager |
Artel (Group) |
Germany |
| Schorr, Joachim (APIS Assay Technologies 202304 CEO before Caris Life Sciences + Qiagen + Hoechst) |
Chief Executive Officer (CEO) |
APIS Assay Technologies (Group) |
United Kingdom (GB) |
| Schorre, Chris (Emergo Group 201002 VP Global Marketing) |
Sales Manager / Marketing Manager |
Emergo Group (Group) |
United States (USA) |
| Schottelius, Arndt (Kymab 201806 EVP RnD before MorphoSys 200812–201701 Chief Developm Officer before Genentech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Schouten, Govert (Kiadis 202007– Head of Innovation before Idmon Consulting + myTomorrows + Mucosis + Crucell Vaccines) |
Research & Development Manager |
Kiadis (Group) |
Netherlands |
| Schrader, Michael (BioVisioN 199904) |
n. a. |
Digilab (Group) |
Germany |
| Schranz, Jennifer (Nabriva 201811 CMO) |
Chief Medical Officer (CMO) |
Nabriva (Group) |
Ireland, Republic of |
| Schreiber, Alain (ProQuest Investments 201201 General Partner) |
General Partner (venture partner) |
ProQuest Investments |
United States (USA) |
| Schreiber, André (Danaher 201504 Food + Environmental Global Applications Manager at Sciex Toronto) |
Professor |
Danaher (Group) |
Canada |
| Schreiber, Kfir (DeepCure 202111 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
DeepCure Inc. |
United States (USA) |
| Schreiner, George (Raven Biotechnologies 200807 CEO) |
Chief Executive Officer (CEO) |
MacroGenics (Group) |
United States (USA) |
| Schrems, Angelika (Bionter 202305 Global Head of Business Development) |
Business Development Manager / Strategy Manager |
Bionter AG |
Switzerland |
| Schreyer, Markus (Thermo Fisher 200805 VP + General Manager Material Characterization) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Schrickx, Harry (OncoMethylome 200601) |
n. a. |
MDxHealth (Group) |
United States (USA) |
| Schrimpf, Gangolf (Merck (DE) 201708) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| Schriver Højskov, Carsten (Aarhus Univ 201508 at Aarhus Univ Hospital) |
Researcher (university / research institute) |
Aarhus University |
Denmark |
| Schroeder, Carsten (Grifols 201407 President of Grifols Diagnostic Solutions Inc.) |
President/Director/Head Business Group/Unit/Division |
Grifols (Group) |
United States (USA) |
| Schroeder, Ted (Nabriva 201807– CEO before Zavante Therapeutics + Cadence Pharmaceuticals + Élan) |
Chief Executive Officer (CEO) |
Nabriva (Group) |
Ireland, Republic of |
| Schroff, Matthias (Vaximm 201609– CEO before Mologen CEO) |
Chief Executive Officer (CEO) |
Vaximm (Group) |
Switzerland |
| Schropp, Carola (EBD Group 201112 President) |
President/Director/Head Business Group/Unit/Division |
Informa (Group) [NEW] |
United States (USA) |
| Schropp, Katharina (Informa 201812 EBD Group) |
Managing Director |
Informa (Group) [NEW] |
Switzerland |
| Schrott, Carl (Sigma-Aldrich 200811 Director Marketing for Regenerative Medicine + Research Cell Culture) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
United States (USA) |
| Schruender, Robert (Sekisui 201905 CEO of Sekisui Diagnostics + Sekisui Medical Board Member) |
Chief Executive Officer (CEO) |
Sekisui (Group) |
United States (USA) |
| Schröder, Christoph (JSB Partners 200308) |
Board member, non-executive |
JSB Partners L.P. |
|
| Schröder, Peer Nils (Basilea 201109 Head Public Relations + Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Basilea (Group) |
Switzerland |
| Schröder, Thilo (Nextech Invest 201607 Partner) |
Partner (venture partner) |
Nextech (Group) |
Switzerland |
| Schub, Oliver (Icosagen 202302 Senior Director Business Development of Icosagen Cell Factory) |
Business Development Manager / Strategy Manager |
Icosagen (Group) |
Estonia |
| Schubert, Christian R. (AbbVie 202401 Head of AbbVie Ventures) |
n. a. |
AbbVie (Group) |
United States (USA) |
| Schubert, Eric (Seismic Marketing 201811) |
Public Relations Manager / Investor Relations Manager |
Seismic Marketing LLC |
United States (USA) |
| Schubert, Jeremy (3EO Health 202208 CEO before Abbott) |
Chief Executive Officer (CEO) |
3EO Health Inc. |
|
| Schubert, Michael (Bruker 200908 Managing Director Bruker Daltonik GmbH) |
Managing Director |
Bruker (Group) |
Germany |
| Schubert, Sören (Univ München 201007 Research Group Leader Max von Pettenkofer Institute) |
Researcher (university / research institute) |
Max von Pettenkofer Institute for Hygiene and Medical Microbiology of LMU München |
Germany |
| Schuck, Regina (Agilent 201008 General Manager Research Products Division) |
General Manager (management) |
Agilent (Group) |
United States (USA) |
| Schudiske, Eric (s2s Public Relations 201705– CEO + Founder) |
Chief Executive Officer (CEO) |
s2s Public Relations and Communications |
United States (USA) |
| Schuele, Peter (VWR 201404 President European Lab Business) |
President/Director/Head Business Group/Unit/Division |
Avantor (Group) |
United States (USA) |
| Schueren, Robert (Agilent 201001– VP + General Manager Genomics before Genentech) |
General Manager (management) |
Agilent (Group) |
United States (USA) |
| Schueren, Robert (Arcturus 200502 COO) |
Chief Operating Officer (COO) |
Hologic (Group) |
United States (USA) |
| Schuetz, Thomas (Compass Therapeutics 201807 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Compass Therapeutics LLC |
United States (USA) |
| Schug, Kevin (Univ Texas 201204 Assoc Professor + Head of Shimadzu Center for Advanced Analytical Chemistry ATU) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Texas System |
United States (USA) |
| Schuh, Antonius (Toni) (Global Source Ventures 202001 Managing Partner before Trovagene + AviaraDx/Arcturus + Sequenom) |
Chief Executive Officer (CEO) |
Trovagene Inc. |
United States (USA) |
| Schule, Marylin Mermod (Sophia Genetics 201801– COO joined 201506 as CFO before Benjamin de Rothschild + La Metairie) |
Chief Financial Officer (CFO) |
Sophia Genetics (Group) |
Switzerland |
| Schulenberg-Schell, Helmut (Agilent 201404 Director Business Development Liquid Phase Separations) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
| Schull, David (Russo Partners 201807) |
Public Relations Manager / Investor Relations Manager |
Russo Partners LLC |
United States (USA) |
| Schulman, Amy W. (Polaris Partners 2014– Venture Partner before Pfizer General Counsel) |
Venture Partner |
Polaris Partners (Polaris Ventures) |
United States (USA) |
| Schulman, Jesse (Canbex Therapeutics 201304 CEO) |
Chief Executive Officer (CEO) |
Canbex Therapeutics Ltd. |
United Kingdom (GB) |
| Schulte, Dave (McKesson 202002 Managing Director of McKesson Ventures) |
Managing Director |
McKesson (Group) |
United States (USA) |
| Schultz, John (PGxHealth 200612 SVP Business Development) |
Business Development Manager / Strategy Manager |
Clinical Data (Group) |
United States (USA) |
| Schultz, John A. (Clinical Data 200510– before Pathway Diagnostics Corp) |
n. a. |
Clinical Data (Group) |
United States (USA) |
| Schultz, Kåre (Teva 201709– CEO announced before Lundbeck 201505– CEO before Novo Nordisk COO) |
Chief Executive Officer (CEO) |
Teva (Group) |
Israel |
| Schultz, Peter G. |
n. a. |
Novartis (Group) |
United States (USA) |
| Schultz, Quentin (BioDiagnostics Inc 201502 President) |
President/Director/Head Business Group/Unit/Division |
Eurofins (Group) |
United States (USA) |
| Schulz, Arne (MoBiTec 200809) |
n. a. |
MoBiTec GmbH |
Germany |
| Schulz, Gregor (Biotest 201212 CEO) |
Chief Executive Officer (CEO) |
Grifols (Group) |
Germany |
| Schulz, Olaf (Ametek 201009 Product Manager ICP-OES at SPECTRO) |
Product Manager (personnel) |
AMETEK (Group) |
Germany |
| Schulz-Knappe, Peter (Protagen 201001– head Protein Services before Proteome Sciences plc CEO before BioVisioN CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Freenome (Group) |
Germany |
| Schulze, Gail (YM BioSciences 200605– CEO of US sub before Eximias –200605 CEO) |
Chief Executive Officer (CEO) |
Gilead Sciences (Group) |
United States (USA) |
| Schulze, Jürgen (Sysmex 201401 Managing Director of Sysmex Turkey) |
Managing Director |
Sysmex (Group) |
Turkey |
| Schulze, Stefan (Vifor Pharma 201911 COO + President of Executive Committee) |
Chief Operating Officer (COO) |
Vifor Pharma (Group) |
Switzerland |
| Schumacher, Dominik (Tubulis 201907– Managing Director (CEO) + Co-Founder) |
Managing Director |
Tubulis (Group) |
Germany |
| Schumacher, Jürgen (Algiax 201104– CEO before NewLab BioQuality 200105 CEO + founder + Qiagen founder) |
Chief Executive Officer (CEO) |
Algiax Pharmaceuticals GmbH |
Germany |
| Schumacher, Richard T. (Pressure BioSciences Inc 200703 CEO + founder) |
Chief Executive Officer (CEO) |
Pressure BioSciences Inc. (OTCQB: PBIO) |
United States (USA) |
| Schumacher, Ton (Netherlands Cancer Institute 202009 Principal Investigator + Neogene Therapeutics 202009 Co-Founder) |
Researcher (university / research institute) |
Netherlands Cancer Institute (NKI) (Amsterdam) |
Netherlands |
| Schumm, James (NetBio 201207 VP of Molecular Biology) |
Research & Development Manager |
NetBio Inc. |
United States (USA) |
| Schur, Jonathan (Calliditas Therapeutics 202010– Group General Counsel before Goodwin Procter + Dechert) |
General Counsel / Chief Legal Officer (CLO) |
Calliditas Therapeutics (Group) |
Sweden |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
1 2 3 ... 100 101 102 ... 124 125 126 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
